Percutaneous Robotic Navigation Microwave Ablation Versus CT-guided Microwave Ablation in the Tre… (NCT07389889) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Percutaneous Robotic Navigation Microwave Ablation Versus CT-guided Microwave Ablation in the Treatment of Pulmonary Nodules With Ground-glass Opacity
116 participantsStarted 2026-02-01
Plain-language summary
1. To compare the precision of robot-guided microwave ablation and CT-guided microwave ablation in the treatment of ground-glass nodules.
2. To evaluate the safety of robot-assisted microwave ablation and CT-guided microwave ablation in the treatment of ground-glass nodules.
3. Explore the application potential of robot navigation microwave ablation technology in the treatment of pulmonary nodules.
Who can participate
Age range18 Years – 85 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Aged 18 to 85 years
✓. Nodules measuring 3-30mm with ground-glass opacities constituting ≥75% of the lesion
✓. Preoperative clinical evaluation confirming no hilar or mediastinal lymph node metastasis and no distant metastasis
✓. Patients diagnosed as stage IA primary peripheral lung cancer according to the UICC 8th TNM staging system, and with one of the following conditions:
✓. Preoperative ECOG physical status score is 0/1
✓. ASA score is I-III
✓. Patients voluntarily participate in this study and sign the informed consent form
Exclusion criteria
✕. Smoking cessation duration \<2 weeks
✕. Lesions adjacent to pulmonary artery-vein main trunks
✕. Lesions near the hilum or adjacent to lobar bronchi
✕. Pregnancy or lactation status
✕. Severe mental disorders
✕. History of other malignancies within 5 years
✕. Unstable angina or myocardial infarction within 6 months with coronary angiography showing severe stenosis of major coronary branches